Match!
Enayatullah Baki
ColectomyInfliximabDiscontinuationAdalimumabUlcerative colitis
1Publications
1H-index
9Citations
What is this?
Publications 1
Newest
AIM: To evaluate the outcome of anti-tumor necrosis factor alpha (anti-TNFα) therapy in outpatients with ulcerative colitis at a tertiary referral center. METHODS: All patients with a confirmed diagnosis of ulcerative colitis undergoing therapy with infliximab and/or adalimumab at the outpatient clinic for inflammatory bowel diseases at the University Hospital Heidelberg between January 2011 and February 2014 were retrospectively enrolled. Patients with a follow-up period of less than 6 mo from ...
9 CitationsSource
1